No headlines found.
U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
Business Wire (Tue, 23-Apr 4:05 PM ET)
Business Wire (Mon, 1-Apr 7:30 AM ET)
U.S. Physical Therapy Announces Change in Medicare Rate Reduction for the Remainder of 2024
Business Wire (Mon, 11-Mar 7:00 AM ET)
Business Wire (Fri, 8-Mar 5:15 PM ET)
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2023 Results
Business Wire (Wed, 28-Feb 4:45 PM ET)
Business Wire (Mon, 5-Feb 4:30 PM ET)
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
US Physical Therapy trades on the NYSE stock market under the symbol USPH.
As of April 25, 2024, USPH stock price declined to $100.64 with 10,635 million shares trading.
USPH has a beta of 0.78, meaning it tends to be less sensitive to market movements. USPH has a correlation of 0.10 to the broad based SPY ETF.
USPH has a market cap of $1.52 billion. This is considered a Small Cap stock.
Last quarter US Physical Therapy reported $155 million in Revenue and $.59 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.02.
In the last 3 years, USPH stock traded as high as $131.50 and as low as $73.30.
The top ETF exchange traded funds that USPH belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
USPH has underperformed the market in the last year with a price return of -3.8% while the SPY ETF gained +22.6%. However, in the short term, USPH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.7% vs +3.2% return in SPY. But in the last 2 weeks, USPH shares have been beat by the market, returning -3.4% compared to an SPY return of -2.9%.
USPH support price is $100.79 and resistance is $106.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USPH stock will trade within this expected range on the day.